NCT00148603View on ClinicalTrials.gov

Montelukast in the Treatment of Duodenal Eosinophilia

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

December 31, 2006

Conditions
Eosinophilic GastroenteritisDyspepsia
Interventions
DRUG

montelukast

Trial Locations (1)

64108

Children's Mercy Hospital and Clinics, Kansas City

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Children's Mercy Hospital Kansas City

OTHER

NCT00148603 - Montelukast in the Treatment of Duodenal Eosinophilia | Biotech Hunter | Biotech Hunter